DOI: 10.1515/mr-2023-0005
Nanomedicine sheds new light on cancer immunotherapy
Yingying Yu1
Liangzhu Feng2
Zhuang Liu2
1.Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices,Institute of Functional Nano & Soft Materials(FUNSOM),Soochow University,Suzhou,Jiangsu Province,China2.Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices,Institute of Functional Nano & Soft Materials(FUNSOM),Soochow University,199 Ren'ai Road,Suzhou 215123,Jiangsu Province,China
摘要：Cancer immunotherapy comprising of immune checkpoint blockade(ICB)therapy,immune cell therapies,cancer vaccines and many others represents a profound arsenal in the fight against different types of cancers.However,their overall clinical objective response rates,particularly against most solid tumors,are still not sufficient owing to a variety of reasons including the heterogenous expression of tumor antigens,limited tumor infiltration of effector immune cells,acquired tumor immunosuppression and some other factors.In recent years,various nano-medicine strategies have been proposed to assist cancer immunotherapy via distinct mechanisms,presenting new promises in many published studies.This perspective will thus provide a brief overview regarding the develop-ment of nanomedicine platforms for improving cancer immunotherapy.
机标关键词：immunotherapycancerlightnanomedicinesheds
论文发表日期：2023-04-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：5( 188-192 )
英文信息